We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Vistin Pharma ASA (VISTN) Ordinary Shares NOK1

Sell:22.40 NOK Buy:24.50 NOK Change: 0.1 NOK (0.41%)
Market closed |  Prices as at close on 23 April 2024 | Switch to live prices |
Sell:22.40 NOK
Buy:24.50 NOK
Change: 0.1 NOK (0.41%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 23 April 2024 | Switch to live prices |
Sell:22.40 NOK
Buy:24.50 NOK
Change: 0.1 NOK (0.41%)
Market closed |  Prices as at close on 23 April 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Vistin Pharma ASA is a Norway-based holding company, which operates through its subsidiary Vistin Pharma AS. The Company is engaged in the pharmaceuticals industry. The Company is a producer and supplier of Active Pharmaceutical Ingredients (APIs), which are used in medications for diabetes. Vistin Pharma offering such products: Metformin HCl (API); Metformin DC (direct compressible granules); Customized Particle Distribution (PSD) and Premix (Metformin + MgSt, can be delivered on-request). The Company’s customers are pharmaceutical companies worldwide.

Contact details

Address:
Ostensjoveien 27
OSLO
0661
Norway
Telephone:
+47 (35) 984200
Website:
https://www.vistin.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
VISTN
ISIN:
NO0010734122
Market cap:
1.07 billion NOK
Shares in issue:
44.34 million
Sector:
Pharmaceuticals
Exchange:
Oslo Stock Exchange
Country:
Norway
Currency:
Norwegian Krone
Indices:
Oslo All Share Index

Key personnel

  • Oyvin Broymer
    Chairman of the Board
  • Magnus Tolleshaug
    Chief Executive Officer
  • Alexander Karlsen
    Chief Financial Officer
  • Vegard Heggem
    Vice President Operations
  • Valborg Godal Vold
    Vice President Sales & Marketing
  • Hilde Hagen
    Vice President Quality & Regulatory Affairs

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.